• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含伊维菌素的带棒硅胶植入物用于犬心丝虫感染长期预防的评估。

Evaluation of a covered-rod silicone implant containing ivermectin for long-term prevention of heartworm infection in dogs.

作者信息

Cunningham Craig P, Brown Jenaay M, Jacobson Glenn A, Brandon Malcolm R, Martinod Serge R

机构信息

Smart Drug Systems Inc, Ste 102, 181 S Broad St, Pawcatuck, CT 06379, USA.

出版信息

Am J Vet Res. 2006 Sep;67(9):1564-9. doi: 10.2460/ajvr.67.9.1564.

DOI:10.2460/ajvr.67.9.1564
PMID:16948602
Abstract

OBJECTIVE

To evaluate use of covered-rod (CR) silicone implants containing ivermectin for long-term prevention of infection with Dirofilaria immitisin dogs.

ANIMALS

145 adult male and female dogs.

PROCEDURES

Dogs received implants of different sizes, and ivermectin concentrations and serum ivermectin concentrations were monitored for 16, 57, and 56 weeks, respectively, in 3 preclinical dose selection studies. Ability of implants to prevent infection with D immitis was evaluated in 2 further studies; dogs were challenged with 50 infective third-stage larvae 52 weeks after implant administration and necropsied 145 days after challenge, and the total number of adult heartworms was counted. A field study was then undertaken in which client-owned dogs received an implant and plasma samples were collected at intervals until week 52 for ivermectin analysis and heartworm antigen determination.

RESULTS

Use of the implants resulted in maintenance of an ivermectin concentration > or = 0.2 ng/mL for 12 months. In challenge studies, no treated dogs had adult heartworms, in contrast to untreated dogs, which all had adult heartworms at necropsy. In the field study, dogs treated with an implant had negative results of heartworm antigen testing for 12 months.

CONCLUSIONS AND CLINICAL RELEVANCE

The CR silicone implant containing 7.3 mg of ivermectin was 100% effective in preventing experimental infection with D immitislarvae and resulted in negative results for heartworm antigen in a field trial. This product has the potential to alleviate poor owner compliance with monthly prevention regimens.

摘要

目的

评估含伊维菌素的带膜棒状(CR)硅胶植入物对犬长期预防感染犬恶丝虫的效果。

动物

145只成年雌雄犬。

步骤

在3项临床前剂量选择研究中,给犬植入不同尺寸的植入物,并分别在16周、57周和56周监测伊维菌素浓度及血清伊维菌素浓度。在另外2项研究中评估植入物预防犬恶丝虫感染的能力;在植入物给药52周后,给犬接种50条感染性第三期幼虫,并在接种后145天进行尸检,计算成虫心丝虫的总数。然后进行了一项现场研究,客户拥有的犬接受植入物,并定期采集血浆样本,直至第52周进行伊维菌素分析和心丝虫抗原测定。

结果

使用植入物可使伊维菌素浓度在12个月内维持≥0.2 ng/mL。在攻毒研究中,与未治疗的犬相比,没有一只治疗犬有成虫心丝虫,未治疗的犬在尸检时均有成虫心丝虫。在现场研究中,接受植入物治疗的犬12个月内心丝虫抗原检测结果均为阴性。

结论及临床意义

含7.3 mg伊维菌素的CR硅胶植入物在预防犬恶丝虫幼虫的实验性感染方面100%有效,且在现场试验中的心丝虫抗原检测结果为阴性。该产品有可能改善宠物主人对每月预防方案依从性差的问题。

相似文献

1
Evaluation of a covered-rod silicone implant containing ivermectin for long-term prevention of heartworm infection in dogs.含伊维菌素的带棒硅胶植入物用于犬心丝虫感染长期预防的评估。
Am J Vet Res. 2006 Sep;67(9):1564-9. doi: 10.2460/ajvr.67.9.1564.
2
Efficacy of long-term monthly administration of ivermectin on the progress of naturally acquired heartworm infections in dogs.每月长期给予伊维菌素对犬自然感染心丝虫病进展的疗效。
Vet Parasitol. 2004 Oct 5;124(3-4):259-68. doi: 10.1016/j.vetpar.2004.06.024.
3
Efficacy of an injectable, sustained-release formulation of moxidectin in preventing experimental heartworm infection in mongrel dogs challenged 12 months after administration.莫昔克丁注射用缓释制剂在给药12个月后对受攻击的杂种犬预防实验性心丝虫感染的疗效。
Vet Parasitol. 2005 Mar 10;128(1-2):129-35. doi: 10.1016/j.vetpar.2004.11.010. Epub 2004 Dec 21.
4
Evaluation of ivermectin and milbemycin oxime efficacy against Dirofilaria immitis infections of three and four months' duration in dogs.伊维菌素和米尔贝肟对犬体内持续三到四个月的犬恶丝虫感染的疗效评估。
Am J Vet Res. 1996 Aug;57(8):1189-92.
5
Pharmacokinetics and efficacy of an ivermectin implant for long-term prevention of Dirofilaria immitis infection in dogs.伊维菌素植入剂对犬长期预防犬恶丝虫感染的药代动力学及疗效
Parasitol Res. 2017 Jun;116(6):1723-1728. doi: 10.1007/s00436-017-5448-4. Epub 2017 Apr 22.
6
The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations.大环内酯类犬心丝虫预防药的安全网故事:综述、更新与建议
Vet Parasitol. 2005 Oct 24;133(2-3):197-206. doi: 10.1016/j.vetpar.2005.04.005. Epub 2005 Apr 26.
7
Response of dogs treated with ivermectin or milbemycin starting at various intervals after Dirofilaria immitis infection.在感染犬恶丝虫后不同时间开始用伊维菌素或米尔倍霉素治疗的犬的反应。
Vet Ther. 2001 Summer;2(3):193-207.
8
The prevention of Dirofilaria repens infection with ivermectin/pyrantel chewables.使用伊维菌素/噻嘧啶咀嚼片预防犬恶丝虫感染。
Parassitologia. 1998 Dec;40(4):457-9.
9
Use of melarsomine dihydrochloride (RM 340) for adulticidal treatment of dogs with naturally acquired infections of Dirofilaria immitis and for clinical prophylaxis during reexposure for 1 year.使用二盐酸美拉索明(RM 340)对自然感染犬恶丝虫的犬进行成虫治疗,并在再次暴露1年期间进行临床预防。
Vet Parasitol. 1994 Nov;55(3):221-33. doi: 10.1016/0304-4017(93)00643-D.
10
Evaluation of heat-treating heartworm-positive canine serum samples during treatment with Advantage Multi for Dogs and doxycycline.评价用Advantage Multi for Dogs(犬用万能驱虫药)和多西环素治疗感染心丝虫犬血清样本在治疗过程中的变化。
Parasit Vectors. 2018 Feb 20;11(1):98. doi: 10.1186/s13071-018-2685-z.

引用本文的文献

1
Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle.伊维菌素长效注射制剂对泽布牛奥氏多头绦虫的影响。
Parasite. 2020;27:36. doi: 10.1051/parasite/2020036. Epub 2020 May 18.
2
Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation.针对疟疾消除目标:使用缓慢释放伊维菌素植入剂使阿拉伯按蚊的存活率显著降低六个月以上。
Parasit Vectors. 2018 May 4;11(1):287. doi: 10.1186/s13071-018-2872-y.
3
Pharmacokinetics and efficacy of an ivermectin implant for long-term prevention of Dirofilaria immitis infection in dogs.
伊维菌素植入剂对犬长期预防犬恶丝虫感染的药代动力学及疗效
Parasitol Res. 2017 Jun;116(6):1723-1728. doi: 10.1007/s00436-017-5448-4. Epub 2017 Apr 22.
4
Screening for an ivermectin slow-release formulation suitable for malaria vector control.筛选适用于疟疾媒介控制的伊维菌素缓释制剂。
Malar J. 2015 Mar 5;14:102. doi: 10.1186/s12936-015-0618-2.